| Persuaded search T Mekonnen, Z Murra-Anton, B Pakzad-Hurson arXiv preprint arXiv:2303.13409, 2023 | 6 | 2023 |
| Financial Aid and Early Admissions at Selective Need-Blind Colleges Z Murra-Anton Available at SSRN 3451291, 2019 | 6* | 2019 |
| Cost-effectiveness analysis of intravitreal aflibercept compared with ranibizumab-prn in patients with wet age-related macular degeneration (Wamd) ZAM Anton Value in Health 18 (7), A880, 2015 | 4 | 2015 |
| Mediated (Anti) Persuasive Communication Z Murra-Anton, R Serrano Available at SSRN 4336458, 2023 | 1* | 2023 |
| The Public Housing Allocation Problem Z Murra-Anton, ISON England, N Thakral | | 2024 |
| Decentralized Matching Platforms: Design and Welfare Z Murra-Anton Available at SSRN 4451720, 2023 | | 2023 |
| Behavioral Real Options, Financial Literacy, and Investor's Inertia Z Murra-Anton Financial Literacy, and Investor's Inertia (December 29, 2021), 2021 | | 2021 |
| COST-EFFECTIVENESS ANALYSIS OF THE DRUGS REIMBURSED BY THE MEXICAN PUBLIC HEALTH SYSTEM (MPHS) FOR THE SECOND-LINE TREATMENT OF PD-L1 POSITIVE, ADVANCED NON-SMALL-CELL LUNG … MZA Anton, C Baptista VALUE IN HEALTH 20 (5), A109-A109, 2017 | | 2017 |
| COST-EFFECTIVENESS ANALYSIS OF PORACTANT ALPHA (200MG/KG DAILY) COMPARED TO BERACTANT (100MG/KG DAILY), IN PREMATURE INFANTS WITH RESPIRATORY DISTRESS SYNDROME, FROM THE … ZA Murra Anton, JA Paladio-Hemandez, MS Anton, C Baptista VALUE IN HEALTH 20 (5), A204-A204, 2017 | | 2017 |
| Cost-Minimization Analysis of Intravitreal Aflibercept Compared with Ranibizumab on-Label In Patients with wet Age-Related Macular Degeneration (Wamd) ZAM Anton Value in Health 18 (7), A881, 2015 | | 2015 |
Bobak Pakzad-HursonBrown University在 brown.edu 的电子邮件经过验证
Bobak Pakzad-HursonBrown University在 brown.edu 的电子邮件经过验证
Neil ThakralBrown University在 brown.edu 的电子邮件经过验证